Skip to content
FrontierPicks

Dormant

JRSH · Jerash Holdings (US), Inc.

Last analysed ·

Current thesis

Jerash Holdings’ sourcing-migration story depends on another quarter meeting guidance. Fiscal Q2 revenue of at least $49 million and gross margin of at least 14% would confirm the case before a weekly close below $4.80 invalidates the price structure.

Kill line

A weekly close below $4.80 invalidates the price-continuation thesis; fiscal Q2 FY2027 revenue below $49 million or gross margin below 14% would separately break the operating case against management’s 2026-08-10 guidance.

Pick status

Open commitment scored if the kill line above fires How this is scored →

Latest analysis and events for JRSH —

As of 19 September 2026, the latest FrontierPicks analysis for Jerash Holdings (US), Inc. (JRSH): Jerash Holdings’ sourcing-migration story depends on another quarter meeting guidance. Fiscal Q2 revenue of at least $49 million and gross margin of at least 14% would confirm the case before a weekly close below $4.80 invalidates the price structure.

Kill line: A weekly close below $4.80 invalidates the price-continuation thesis; fiscal Q2 FY2027 revenue below $49 million or gross margin below 14% would separately break the operating case against management’s 2026-08-10 guidance.

Current Thesis

Jerash Holdings’ sourcing-migration thesis depends on Jordan-made apparel converting demand into another quarter within guidance; fiscal second-quarter revenue and margin will test that case, while a weekly close below $4.80 invalidates its price structure. Management’s 2026-08-10 outlook called for fiscal Q2 revenue of $49–51 million and gross margin of 14–15%, following fiscal Q1 revenue of $50.23 million. Those published ranges define the operating test.

The change since the 2026-09-05 note is a return to the supplied adjusted 52-week high: JRSH closed at $5.64 on 2026-09-18. The September governance event also resolved: shareholders elected all five nominees, including Ng Tsze Lun, at the 2026-09-10 annual meeting. The resulting filing reports voting outcomes rather than a revenue or guidance update. September 11 Form 8-K.

The narrative is maturing — an inference from the 2026-08-10 earnings confirmation, the elapsed 2026-09-10 conference window and the absence of a subsequent operating release in the company’s retrieved news index. That sequence establishes the age of the story; it does not establish weakening demand or broader investor participation. Company news index.

Bullish and bearish views on Jerash Holdings (US), Inc.

The model's bull view on Jerash Holdings (US), Inc. (JRSH), in brief: Revenue exceeded management’s outlook. Fiscal Q1 FY2027 revenue of $50.23 million, reported 2026-08-10, exceeded the $47.52–48.31 million range issued on 2026-06-15 and increased 26.7% year over year. This supports the sourcing thesis through reported shipments rather than… The bear view: Guidance allows a margin retreat. Management’s 2026-08-10 fiscal Q2 gross-margin outlook of 14–15% sits below fiscal Q1’s reported 16.4%. The sourcing thesis therefore cannot assume that the latest margin repeats. Sequential growth remains unproven. The $49–51 million fiscal Q2… Both cases follow in full.

Bull Case

  • Revenue exceeded management’s outlook. Fiscal Q1 FY2027 revenue of $50.23 million, reported 2026-08-10, exceeded the $47.52–48.31 million range issued on 2026-06-15 and increased 26.7% year over year. This supports the sourcing thesis through reported shipments rather than capacity announcements alone.
  • Profit growth accompanied shipment growth. The 2026-08-10 results reported gross profit of $8.3 million, up 35.7%, and operating income of $2.6 million, up 174% year over year. Gross margin was 16.4%.
  • Expansion has an operating milestone. Management’s 2026-08-10 call described approximately 15% additional capacity and about 500 workers by the end of 2026. That is a company forecast, not delivered capacity; a subsequent disclosure postponing completion beyond 2026 would invalidate its timing.

Bear Case

  • Guidance allows a margin retreat. Management’s 2026-08-10 fiscal Q2 gross-margin outlook of 14–15% sits below fiscal Q1’s reported 16.4%. The sourcing thesis therefore cannot assume that the latest margin repeats.
  • Sequential growth remains unproven. The $49–51 million fiscal Q2 revenue range issued on 2026-08-10 brackets fiscal Q1’s $50.23 million. The outlook supports continued volume, but does not establish sequential acceleration.
  • Freight remains an operating constraint. The 2026-08-10 earnings call flagged logistics costs associated with exports through Haifa. Fiscal Q2 revenue below $49 million with shipment delays cited, or gross margin below 14% with freight cited, would confirm that this constraint has impaired the operating case.

Setup & Price Structure

The measured 2026-09-18 adjusted close was $5.64, equal to the supplied 52-week high, with a three-month price increase of 23.0%. The 14-day relative strength index (RSI) was 57.1. Price has reached the high; this observation alone does not establish a sustained breakout above it.

The $4.80 weekly-close threshold remains the published thesis-invalidation level. It is an analytical condition, not a moving average or a newly verified support measurement. No moving-average value or current volume series is available in the supplied price evidence, so neither distance above trend nor expanding participation can be quantified.

The dated attention evidence is narrower than a current crowding claim: Benzinga reported an upside circuit-breaker halt on 2026-06-15, and the 2026-09-05 coverage snapshot counted two analysts. Neither observation measures present short interest, retail ownership or demand at the 2026-09-18 high. The available sample is too small to support a squeeze conclusion; the research frame is an emerging single-company sourcing thesis.

Catalyst Calendar (next 30 days)

  • 2026-09-19 through 2026-10-19: No company-confirmed event was identified for this window. The retrieved investor calendar displayed no upcoming dated entries; this is a verification limit, not proof that an announcement cannot occur. Company event calendar.
  • ~2026-11-12, estimated: Fiscal Q2 FY2027 results are the later event on which the operating thesis turns. The timing estimate follows the company’s 2025-11-12 fiscal Q2 release and remains unconfirmed. The report tests the $49–51 million revenue and 14–15% gross-margin guidance issued on 2026-08-10. Company release archive.

What Would Change Our Mind

Loss of the published price threshold would break the continuation case: a weekly close below $4.80 is the observable invalidation. Independently, fiscal Q2 revenue below $49 million or gross margin below 14% would miss the respective floors of management’s 2026-08-10 guidance and defeat the defined operating case.

The positive case is fulfilled if fiscal Q2 revenue reaches at least $49 million and gross margin reaches at least 14% before the price invalidation occurs. Until that report, the 2026-09-18 return to $5.64 confirms price recovery without resolving whether the next quarter meets guidance.

Correlation Notes

This remains a single-name setup. Management identified VF Corporation as the largest customer on the 2026-08-10 call, making customer orders a direct operating exposure. The same call’s discussion of Haifa logistics establishes a separate shipping exposure.

Neither relationship supplies a measured equity-price correlation. The supplied 2026-09-18 price snapshot contains no peer return series, so it cannot establish that small-cap rotation or consumer-discretionary strength explains JRSH’s advance.

Notes

  • Fiscal year ends March 31: "Q1 FY2027" is the calendar quarter ended 2026-06-30. Check period labels before comparing to peers.
  • Customer concentration is structural: VF Corp is the largest customer (2026-08-10 call); FY2022 disclosure showed VF ~67% and New Balance ~24% of sales.
  • Micro-cap float — 12.70M shares outstanding, $70.23M market cap (2026-09-05) — with an upside circuit-breaker halt on record (2026-06-15, +36.13%). Price moves in gaps.
  • Sell-side coverage is two analysts with a $6.50 consensus target (stockanalysis.com poll, 2026-09-05); there is no broad institutional research base anchoring valuation.
  • A $100M mixed-securities shelf (Form S-3, preliminary prospectus dated 2025-02-24) is on file, so issuance would need no new registration. Nothing has been announced under it.
  • Manufacturing is in Jordan with exports via Haifa; the board and annual meeting are in Hong Kong. Duty-free US access runs through the US–Jordan FTA.

Related · shared themes

See also · stocks to watch